FDA declines to approve Merck and Eisai's liver cancer combo therapy

The U.S. drug regulator declined to approve a combination of Merck & Co Inc's blockbuster cancer drug Keytruda and Eisai Co Ltd's Lenvima as the first line of treatment in patients with liver cancer, the companies said on Wednesday.

Exclusive: EU reaches deals with Roche, Merck for supply of COVID-19 drugs - source

The European Commission has reached agreements with pharmaceutical companies Roche and Merck KGaA to supply experimental drugs that can be used to treat COVID-19 patients, a commission source told Reuters on Wednesday.

Spain's Catalonia makes masks compulsory in public at all times

Catalonia on Wednesday ordered all residents and visitors to wear face masks in public at all times, becoming the first Spanish region to toughen a national directive mandating their use when in close proximity to others.

UK tech firm Smiths Group to help make COVID-19 antibody test

Britain's Smiths Group on Wednesday said it would help produce a blood-based COVID-19 antibody test approved by the country's regulators, another move by the technology firm to develop products to combat the pandemic.

Iran coronavirus death toll exceeds 12,000 as lockdown curbs ease

Iran's coronavirus death toll exceeded 12,000 on Wednesday, the health ministry said, with 153 deaths in the past 24 hours, amid a sharp rise in the number of daily infections and deaths in the past week as lockdown measures have eased.

Free ambulance helps save mothers and babies in Kenya lockdown

As soon as Kenya introduced a coronavirus curfew, Dr. Jemimah Kariuki, an obstetrician-gynecologist at Nairobi's Kenyatta Hospital, started seeing more death and complications.

In Africa, lack of coronavirus data raises fears of 'silent epidemic'

When the new coronavirus hit Tanzania in mid-April, President John Magufuli called for three days of national prayer to seek God’s protection from the scourge. Barely a month later, he claimed victory over the disease and invited tourists to return to his East African nation.

What you need to know about the coronavirus right now

Here's what you need to know about the coronavirus right now:

South Korea seeks remdesivir to treat over 5,000 COVID patients: lawmaker

South Korea has asked Gilead Sciences Inc's to supply enough of its anti-viral drug remdesivir to treat more than 5,000 COVID-19 patients in preparation for a potential second wave of infections, an opposition lawmaker said on Wednesday.

WHO's Tedros pulls out of UK event after U.S. confirms to exit WHO

World Health Organization chief Tedros Adhanom Ghebreyesus pulled out of a London event at the last minute on Wednesday after organisers said he had to attend meetings linked to the U.S. notification of its withdrawal from the WHO.

Uzbekistan to introduce second lockdown from July 10

Uzbekistan will impose a second lockdown between July 10 and Aug. 1 to curb a new surge in cases of the novel coronavirus since the easing of its first set of restrictions in late May and early June.

Related Videos

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS